Fresofol 1% (Propofol)

Anaesthesiology and intensive care, Fresenius Kabi has developed Fresofol (Propofol 1% Fresenius); an ideal intravenous anaesthetic drug. Fresofol (Propofol 1% Fresenius) is a lipid emulsion containing Propofol, and is a preferred drug for the induction and maintenance of general anaesthesia as well as the sedation of ventilated patients receiving intensive care.

Features:

Benefits:

• Approved for use in infants above one month
• Rapid onset of action
• Safe regulation of sedation level
• Significant reduction of nausea and vomiting
• Fast recovery and clear consciousness

Characteristics:

• 1 ml emulsion contains 10 mg Propofol, soybean oil, purified egg phosphatide, glycerol, oleic acid, sodium hydroxide and water for injection

Indications:

• For induction and maintenance of general anaesthesia
• For sedation of ventilated patients receiving intensive care
• Total intravenous anaesthesia

Presentation: 20 ml glass ampoules 50 ml glass vials